Westlake Chemical Partners LP
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.17B | $1.14B | $1.19B | $1.59B | $1.21B | $966.7M | $1.09B | $1.29B |
| Cost of Revenue | $818.8M | $717.0M | $803.3M | $1.22B | $773.2M | $587.8M | $712.4M | $908.5M |
| Gross Profit | $347.8M | $418.9M | $387.5M | $377.4M | $441.7M | $378.9M | $379.4M | $377.2M |
| Gross Margin | 29.8% | 36.9% | 32.5% | 23.7% | 36.4% | 39.2% | 34.8% | 29.3% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $28.3M | $28.5M | $29.8M | $29.7M | $31.0M | $25.9M | $29.3M | $27.6M |
| Operating Income | $319.6M | $390.4M | $357.7M | $347.7M | $410.7M | $353.0M | $350.2M | $349.6M |
| Operating Margin | 27.4% | 34.4% | 30.0% | 21.8% | 33.8% | 36.5% | 32.1% | 27.2% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $299.1M | $370.0M | $335.4M | $335.8M | $401.9M | $341.7M | $333.6M | $330.6M |
| Income Tax Expense | $547.0K | $835.0K | $813.0K | $1.0M | $549.0K | $564.0K | $728.0K | $22.0K |
| Net Income | $48.7M | $62.4M | $54.3M | $64.2M | $82.5M | $66.2M | $61.0M | $49.3M |
| Net Margin | 4.2% | 5.5% | 4.6% | 4.0% | 6.8% | 6.8% | 5.6% | 3.8% |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — | — | — |
| Shares Outstanding (Basic) | 35.2M | 35.2M | 35.2M | — | — | — | — | — |
| Shares Outstanding (Diluted) | 35.2M | 35.2M | 35.2M | — | — | — | — | — |
| Dividends Per Share | — | — | — | — | — | — | — | — |